Skip to main content
. 2022 Jul 7;82:104143. doi: 10.1016/j.ebiom.2022.104143

Figure 1.

Figure 1

Assessment of eTIL% using the NN192 machine learning cell classifier and the established cut-point of 16.6% in the five cohorts from multiple institutions. (a) Kaplan-Meier curves of DSS in WTS NYU validation cohort (b) DSS in WTS Sydney University cohort, (c) OS in WTS TCGA cohort, (e) DSS in TMA Tubingen University Cohort, (f) DSS in TMA Yale University Cohort by eTIL% dichotomised at 16.6 % (G) pathologist's TIL scores. (d) Bar plot depicting the stage distribution of each cohort.